Drug survival of systemic immunosuppressive treatments for atopic dermatitis in a long-term pediatric cohort

Drug survival of systemic immunosuppressive treatments for atopic dermatitis in a long-term pediatric cohort

Background: : Systemic immunosuppressive treatments are central in the treatment of severe atopic dermatitis (AD). Yet, comparative data are sparse on the performance of such immunosuppressive treatments in pediatric cohorts with severe AD. Objective: : This study aimed to examine the drug survival...

Full description

Bibliographic Details
Main Authors: Stine Elsgaard, MBBS, Anna Kathrine Danielsen, MBBS, Jacob P. Thyssen, MD, PhD, DMSc, Mette Deleuran, MD, DMSc, Christian Vestergaard, MD, PhD, DMSc
Format: Article
Language:English
Published: Wolters Kluwer 2021-12-01
Series:International Journal of Women's Dermatology
Subjects:
Atopic dermatitis
pediatric
systemic immunosuppressive treatment
methotrexate
azathioprine
drug survival
Online Access:http://www.sciencedirect.com/science/article/pii/S2352647521000848

Similar Items

Similar Items